Gilead Sciences, Inc. (TSX:GILD)
31.92
+0.51 (1.62%)
Oct 26, 2026, 3:49 PM EDT
Gilead Sciences Employees
Gilead Sciences had 17,000 employees as of December 31, 2025. The number of employees decreased by 600 or 3.41% compared to the previous year.
Employees
17,000
Change (1Y)
-600
Growth (1Y)
-3.41%
Revenue / Employee
2.54M CAD
Profits / Employee
-270.65K CAD
Market Cap
275.86B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 17,000 | -600 | -3.41% |
| Dec 31, 2024 | 17,600 | -400 | -2.22% |
| Dec 31, 2023 | 18,000 | 1,000 | 5.88% |
| Dec 31, 2022 | 17,000 | 2,600 | 18.06% |
| Dec 31, 2021 | 14,400 | 800 | 5.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Extendicare | 23,500 |
| Sienna Senior Living | 15,000 |
| Apotex Health | 6,000 |
| Curaleaf Holdings | 5,554 |
| Green Thumb Industries | 4,900 |
| WELL Health Technologies | 1,507 |
| Knight Therapeutics | 830 |
| Cronos Group | 610 |
Gilead Sciences News
- 3 days ago - The Lanier Law Firm Supports Attorney General Ken Paxton in Reaching $45 Million Settlement with Gilead in Unlawful Inducement Scheme - Business Wire
- 4 days ago - Gilead to acquire IL-23R inhibitor program from PepStar Therapeutics - TheFly
- 4 days ago - Gilead to Acquire Investigational Oral IL-23R Inhibitor HCXT-2001, Strengthening Its Inflammation Pipeline in IBD - Business Wire
- 4 days ago - Texas AG secures $45M settlement with Gilead - TheFly
- 4 days ago - Gilead to present new clinical, real-world evidence across PBC, HDV - TheFly
- 4 days ago - Gilead to Present New Data on Treatment Response and Long-Term Management of Rare Liver Diseases at The Liver Meeting® 2026 - Business Wire
- 4 days ago - BioNTech, Gilead to test drug combination in advanced breast cancer trial - Reuters
- 4 days ago - BioNTech announces collaboration, supply agreement with Gilead - TheFly